SE7805105L - Forfarande for framstellning av pyranokinolinderivat med terapeutisk verkan - Google Patents

Forfarande for framstellning av pyranokinolinderivat med terapeutisk verkan

Info

Publication number
SE7805105L
SE7805105L SE7805105A SE7805105A SE7805105L SE 7805105 L SE7805105 L SE 7805105L SE 7805105 A SE7805105 A SE 7805105A SE 7805105 A SE7805105 A SE 7805105A SE 7805105 L SE7805105 L SE 7805105L
Authority
SE
Sweden
Prior art keywords
pyranokinoline
derivatives
procedure
preparation
therapeutic effect
Prior art date
Application number
SE7805105A
Other languages
English (en)
Other versions
SE443561B (sv
Inventor
H Cairns
D Cox
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of SE7805105L publication Critical patent/SE7805105L/sv
Publication of SE443561B publication Critical patent/SE443561B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
SE7805105A 1977-05-04 1978-05-03 Forfarande for framstellning av pyranokinolinderivat med terapeutisk verkan SE443561B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1859777 1977-05-04
GB4586577 1977-11-04

Publications (2)

Publication Number Publication Date
SE7805105L true SE7805105L (sv) 1978-11-05
SE443561B SE443561B (sv) 1986-03-03

Family

ID=26253475

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7805105A SE443561B (sv) 1977-05-04 1978-05-03 Forfarande for framstellning av pyranokinolinderivat med terapeutisk verkan
SE8602492A SE463920B (sv) 1977-05-04 1986-06-02 Mellanprodukt till anvaendning vid framstaellning av terapeutiskt verksamma pyranokinolinonderivat

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8602492A SE463920B (sv) 1977-05-04 1986-06-02 Mellanprodukt till anvaendning vid framstaellning av terapeutiskt verksamma pyranokinolinonderivat

Country Status (16)

Country Link
JP (2) JPS53137969A (sv)
AU (1) AU520816B2 (sv)
CA (1) CA1112644A (sv)
CH (1) CH634071A5 (sv)
DE (1) DE2819215A1 (sv)
DK (1) DK158266C (sv)
ES (1) ES469391A1 (sv)
FR (1) FR2389627B1 (sv)
IE (1) IE47051B1 (sv)
IL (2) IL54614A (sv)
IT (1) IT1158699B (sv)
LU (2) LU79579A1 (sv)
NL (2) NL184896C (sv)
NO (1) NO154497C (sv)
NZ (1) NZ187156A (sv)
SE (2) SE443561B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2440371A1 (fr) * 1978-10-31 1980-05-30 Fisons Ltd Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
ATE11774T1 (de) * 1979-12-07 1985-02-15 Fisons Plc Verfahren zur herstellung von 1,4-dihydro-4-oxo- chinolin-2-carbonsaeuren oder salzen, estern oder amiden davon und zwischenverbindungen dafuer.
EP0162556B1 (en) * 1984-04-13 1991-11-06 FISONS plc Novels forms and formulations of nedocromil sodium
ES2058129T3 (es) * 1986-12-23 1994-11-01 Fisons Plc Composiciones farmaceuticas que comprenden una solucion acuosa de un derivado de piranoquinolina.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2054503A1 (en) * 1969-07-18 1971-04-23 Bellon Labor Sa Roger 1, 4-dihydro-4-oxo quinolyl-3-carboxylic aci

Also Published As

Publication number Publication date
IL54614A0 (en) 1978-07-31
ES469391A1 (es) 1979-10-01
CH634071A5 (en) 1983-01-14
IL54614A (en) 1983-07-31
JPH01199909A (ja) 1989-08-11
NL7804749A (nl) 1978-11-07
AU3573178A (en) 1979-11-08
FR2389627B1 (sv) 1981-01-02
NL930050I1 (nl) 1993-09-01
IE47051B1 (en) 1983-12-14
IL61826A0 (en) 1981-01-30
IT1158699B (it) 1987-02-25
NL184896C (nl) 1989-12-01
SE8602492L (sv) 1986-06-02
JPH0122276B2 (sv) 1989-04-25
DK190178A (da) 1978-11-05
SE8602492D0 (sv) 1986-06-02
LU79579A1 (fr) 1979-02-02
IT7822918A0 (it) 1978-05-02
NL930050I2 (nl) 1993-11-16
SE463920B (sv) 1991-02-11
NO154497B (no) 1986-06-23
FR2389627A1 (sv) 1978-12-01
JPS53137969A (en) 1978-12-01
NO781549L (no) 1978-11-07
NO154497C (no) 1986-10-01
DK158266C (da) 1990-10-08
NL184896B (nl) 1989-07-03
DE2819215C2 (sv) 1990-12-13
IE780890L (en) 1978-11-04
SE443561B (sv) 1986-03-03
CA1112644A (en) 1981-11-17
DE2819215A1 (de) 1978-11-16
LU88281I2 (fr) 1994-05-04
NZ187156A (en) 1984-03-30
DK158266B (da) 1990-04-23
AU520816B2 (en) 1982-03-04

Similar Documents

Publication Publication Date Title
SE434395B (sv) Analogiforfarande for framstellning av karbostyrilderivat med terapeutisk verkan
SE7805590L (sv) Forfarande for framstellning av aminoalkylderivat med farmaceutisk verkan
SE7805591L (sv) Forfarande for framstellning av aminoalkylbensen-derivat med farmaceutisk verkan
SE7812268L (sv) Fenylglycinderivat med terapeutisk verkan
NO782756L (no) Fremgangsmaate for fremstilling av terapeutisk aktive antrakinonderivater
SE429338B (sv) Forfarande for framstellning av substituerade 2-bensylpyrrolidiner med terapeutisk verkan
SE7803035L (sv) Forfarande for framstellning av tienopyridinderivat
SE7804736L (sv) Forfarande for framstellning av isoindolinderivat med terapeutisk verkan
SE411671B (sv) Forfarande for framstellning av tripeptidderivat med terapeutisk verkan
NO784382L (no) Fremgangsmaate for fremstilling av tiazoldin-derivater
SE7800930L (sv) Forfarande for framstellning av bensensulfonamid- och bensenkarboxamidderivat med terapeutisk verkan
SE7703721L (sv) Forfarande for framstellning av hexahydroprimidinforeningar med terapeutisk verkan
SE7600343L (sv) Forfarande for framstellning av ferrocenderivat med terapeutisk verkan
SE7608538L (sv) Forfarande for framstellning av substituerade fenylalkylaminoalkylbensenderivat med terapeutisk verkan
SE7608115L (sv) Forfarande for framstellning av kinoxalinderivat med terapeutisk verkan
SE7805105L (sv) Forfarande for framstellning av pyranokinolinderivat med terapeutisk verkan
NO780389L (no) Fremgangsmaate for fremstilling av erytromycin-derivater
NO145656C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyletanolaminderivater
SE7712219L (sv) Forfarande for framstellning av trans-5a-aryl-dekahydrobenzazpiner med terapeutisk verkan
SE7708521L (sv) Forfarande for framstellning av aminoalkylfuranderivat med terapeutisk verkan
SE7710057L (sv) Forfarande for framstellning av substituerade 1-sulfonylbensimidazoler med terapeutisk verkan
SE7710055L (sv) Forfarande for framstellning av substituerade 1-sulfonylbensimidazoler med terapeutisk verkan
SE7710054L (sv) Forfarande for framstellning av substituerade 1-sulfonylbensimidazoler med terapeutisk verkan
SE417712B (sv) Forfarande for framstellning av n-(6-acyloxibensotiazol-2-yl)-nŸ-fenylkarbamider med terapeutisk verkan
SE411119B (sv) Analogiforfarande for framstellning av l-indolin-l-yl-guanidinderivat med terapeutisk verkan

Legal Events

Date Code Title Description
SPCF Application for supplementary protection certificate filed

Free format text: 7805105

NAL Patent in force

Ref document number: 7805105-9

Format of ref document f/p: F

SPCG Supplementary protection certificate granted

Free format text: 9490184, 940422, EXPIRES: 20010423

NUG Patent has lapsed

Ref document number: 7805105-9

Format of ref document f/p: F